News search

A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.

The protein, OMA1, delays immune-system overactivation, liver fibrosis, and liver cancer during aging

Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy

The findings suggest that a risk-based personalized approach may be more efficient than applying intensive surveillance protocols uniformly to all patients. 

The study reveals that the early heart is shaped by distinct but closely coordinated patterns of tissue deformation 

The young Lithuanian researcher was recognised for a project on new molecular targets for the antiviral treatment of intestinal infections 

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes